nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—Nucleoside Analog—Azathioprine—systemic lupus erythematosus	0.756	1	CiPCiCtD
Abacavir—UGT1A1—Mycophenolate mofetil—systemic lupus erythematosus	0.0922	1	CbGbCtD
Abacavir—ADH6—nephron tubule—systemic lupus erythematosus	0.00665	0.151	CbGeAlD
Abacavir—ADH6—kidney—systemic lupus erythematosus	0.00585	0.133	CbGeAlD
Abacavir—ADH6—cortex of kidney—systemic lupus erythematosus	0.00569	0.13	CbGeAlD
Abacavir—UGT1A1—urine—systemic lupus erythematosus	0.00565	0.129	CbGeAlD
Abacavir—ADH6—lung—systemic lupus erythematosus	0.00414	0.0943	CbGeAlD
Abacavir—UGT1A1—blood plasma—systemic lupus erythematosus	0.00295	0.0671	CbGeAlD
Abacavir—ADK—nephron tubule—systemic lupus erythematosus	0.00154	0.0351	CbGeAlD
Abacavir—ADK—skin of body—systemic lupus erythematosus	0.00144	0.0327	CbGeAlD
Abacavir—ADK—kidney—systemic lupus erythematosus	0.00135	0.0308	CbGeAlD
Abacavir—UGT1A1—kidney—systemic lupus erythematosus	0.00134	0.0304	CbGeAlD
Abacavir—ADK—cortex of kidney—systemic lupus erythematosus	0.00132	0.03	CbGeAlD
Abacavir—ADK—lymphoid tissue—systemic lupus erythematosus	0.00116	0.0265	CbGeAlD
Abacavir—ADK—tendon—systemic lupus erythematosus	0.00109	0.0249	CbGeAlD
Abacavir—ADK—bone marrow—systemic lupus erythematosus	0.00106	0.0241	CbGeAlD
Abacavir—ADK—lung—systemic lupus erythematosus	0.00096	0.0218	CbGeAlD
Abacavir—ADK—nervous system—systemic lupus erythematosus	0.000889	0.0202	CbGeAlD
Abacavir—ADK—central nervous system—systemic lupus erythematosus	0.000856	0.0195	CbGeAlD
Abacavir—Dermatitis—Leflunomide—systemic lupus erythematosus	8.27e-05	0.000765	CcSEcCtD
Abacavir—Nausea—Azathioprine—systemic lupus erythematosus	8.25e-05	0.000764	CcSEcCtD
Abacavir—Headache—Leflunomide—systemic lupus erythematosus	8.22e-05	0.000761	CcSEcCtD
Abacavir—Skin disorder—Methylprednisolone—systemic lupus erythematosus	8.21e-05	0.00076	CcSEcCtD
Abacavir—Malnutrition—Prednisone—systemic lupus erythematosus	8.21e-05	0.00076	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	8.2e-05	0.000759	CcSEcCtD
Abacavir—Convulsion—Dexamethasone—systemic lupus erythematosus	8.16e-05	0.000756	CcSEcCtD
Abacavir—Convulsion—Betamethasone—systemic lupus erythematosus	8.16e-05	0.000756	CcSEcCtD
Abacavir—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	8.14e-05	0.000754	CcSEcCtD
Abacavir—Insomnia—Hydrocortisone—systemic lupus erythematosus	8.14e-05	0.000754	CcSEcCtD
Abacavir—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	8.08e-05	0.000748	CcSEcCtD
Abacavir—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	8.08e-05	0.000748	CcSEcCtD
Abacavir—Urticaria—Cyclosporine—systemic lupus erythematosus	8.05e-05	0.000745	CcSEcCtD
Abacavir—Myalgia—Betamethasone—systemic lupus erythematosus	8.02e-05	0.000743	CcSEcCtD
Abacavir—Myalgia—Dexamethasone—systemic lupus erythematosus	8.02e-05	0.000743	CcSEcCtD
Abacavir—Abdominal pain—Cyclosporine—systemic lupus erythematosus	8.01e-05	0.000741	CcSEcCtD
Abacavir—Body temperature increased—Cyclosporine—systemic lupus erythematosus	8.01e-05	0.000741	CcSEcCtD
Abacavir—Anxiety—Dexamethasone—systemic lupus erythematosus	7.99e-05	0.00074	CcSEcCtD
Abacavir—Anxiety—Betamethasone—systemic lupus erythematosus	7.99e-05	0.00074	CcSEcCtD
Abacavir—Discomfort—Dexamethasone—systemic lupus erythematosus	7.93e-05	0.000734	CcSEcCtD
Abacavir—Discomfort—Betamethasone—systemic lupus erythematosus	7.93e-05	0.000734	CcSEcCtD
Abacavir—Hypotension—Methylprednisolone—systemic lupus erythematosus	7.9e-05	0.000731	CcSEcCtD
Abacavir—Pain—Prednisolone—systemic lupus erythematosus	7.88e-05	0.00073	CcSEcCtD
Abacavir—Hepatitis—Methotrexate—systemic lupus erythematosus	7.88e-05	0.000729	CcSEcCtD
Abacavir—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	7.85e-05	0.000727	CcSEcCtD
Abacavir—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	7.82e-05	0.000724	CcSEcCtD
Abacavir—Pharyngitis—Methotrexate—systemic lupus erythematosus	7.82e-05	0.000724	CcSEcCtD
Abacavir—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	7.81e-05	0.000723	CcSEcCtD
Abacavir—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	7.81e-05	0.000723	CcSEcCtD
Abacavir—Nausea—Leflunomide—systemic lupus erythematosus	7.79e-05	0.000722	CcSEcCtD
Abacavir—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	7.77e-05	0.000719	CcSEcCtD
Abacavir—Fatigue—Hydrocortisone—systemic lupus erythematosus	7.76e-05	0.000718	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	7.72e-05	0.000715	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	7.7e-05	0.000713	CcSEcCtD
Abacavir—Pain—Hydrocortisone—systemic lupus erythematosus	7.7e-05	0.000712	CcSEcCtD
Abacavir—Oedema—Dexamethasone—systemic lupus erythematosus	7.69e-05	0.000712	CcSEcCtD
Abacavir—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	7.69e-05	0.000712	CcSEcCtD
Abacavir—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	7.69e-05	0.000712	CcSEcCtD
Abacavir—Oedema—Betamethasone—systemic lupus erythematosus	7.69e-05	0.000712	CcSEcCtD
Abacavir—Insomnia—Triamcinolone—systemic lupus erythematosus	7.67e-05	0.00071	CcSEcCtD
Abacavir—Insomnia—Methylprednisolone—systemic lupus erythematosus	7.65e-05	0.000708	CcSEcCtD
Abacavir—Infection—Dexamethasone—systemic lupus erythematosus	7.64e-05	0.000707	CcSEcCtD
Abacavir—Infection—Betamethasone—systemic lupus erythematosus	7.64e-05	0.000707	CcSEcCtD
Abacavir—Ill-defined disorder—Prednisone—systemic lupus erythematosus	7.61e-05	0.000705	CcSEcCtD
Abacavir—Paraesthesia—Triamcinolone—systemic lupus erythematosus	7.61e-05	0.000704	CcSEcCtD
Abacavir—Feeling abnormal—Prednisolone—systemic lupus erythematosus	7.59e-05	0.000703	CcSEcCtD
Abacavir—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	7.59e-05	0.000703	CcSEcCtD
Abacavir—Anaemia—Prednisone—systemic lupus erythematosus	7.58e-05	0.000702	CcSEcCtD
Abacavir—Dyspnoea—Triamcinolone—systemic lupus erythematosus	7.56e-05	0.000699	CcSEcCtD
Abacavir—Nervous system disorder—Betamethasone—systemic lupus erythematosus	7.54e-05	0.000698	CcSEcCtD
Abacavir—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	7.54e-05	0.000698	CcSEcCtD
Abacavir—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	7.53e-05	0.000697	CcSEcCtD
Abacavir—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	7.53e-05	0.000697	CcSEcCtD
Abacavir—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	7.46e-05	0.000691	CcSEcCtD
Abacavir—Erythema multiforme—Methotrexate—systemic lupus erythematosus	7.45e-05	0.000689	CcSEcCtD
Abacavir—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	7.42e-05	0.000687	CcSEcCtD
Abacavir—Malaise—Prednisone—systemic lupus erythematosus	7.4e-05	0.000685	CcSEcCtD
Abacavir—Vertigo—Prednisone—systemic lupus erythematosus	7.37e-05	0.000682	CcSEcCtD
Abacavir—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	7.36e-05	0.000681	CcSEcCtD
Abacavir—Anorexia—Dexamethasone—systemic lupus erythematosus	7.33e-05	0.000679	CcSEcCtD
Abacavir—Anorexia—Betamethasone—systemic lupus erythematosus	7.33e-05	0.000679	CcSEcCtD
Abacavir—Urticaria—Prednisolone—systemic lupus erythematosus	7.32e-05	0.000678	CcSEcCtD
Abacavir—Fatigue—Triamcinolone—systemic lupus erythematosus	7.31e-05	0.000676	CcSEcCtD
Abacavir—Fatigue—Methylprednisolone—systemic lupus erythematosus	7.29e-05	0.000675	CcSEcCtD
Abacavir—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	7.28e-05	0.000674	CcSEcCtD
Abacavir—Asthenia—Cyclosporine—systemic lupus erythematosus	7.27e-05	0.000673	CcSEcCtD
Abacavir—Pain—Triamcinolone—systemic lupus erythematosus	7.25e-05	0.000671	CcSEcCtD
Abacavir—Hypotension—Betamethasone—systemic lupus erythematosus	7.19e-05	0.000665	CcSEcCtD
Abacavir—Hypotension—Dexamethasone—systemic lupus erythematosus	7.19e-05	0.000665	CcSEcCtD
Abacavir—Pruritus—Cyclosporine—systemic lupus erythematosus	7.17e-05	0.000663	CcSEcCtD
Abacavir—Urticaria—Hydrocortisone—systemic lupus erythematosus	7.15e-05	0.000662	CcSEcCtD
Abacavir—Immune system disorder—Methotrexate—systemic lupus erythematosus	7.12e-05	0.000659	CcSEcCtD
Abacavir—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	7.11e-05	0.000659	CcSEcCtD
Abacavir—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	7.11e-05	0.000659	CcSEcCtD
Abacavir—Convulsion—Prednisone—systemic lupus erythematosus	7.11e-05	0.000658	CcSEcCtD
Abacavir—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	7.09e-05	0.000656	CcSEcCtD
Abacavir—Chills—Methotrexate—systemic lupus erythematosus	7.07e-05	0.000654	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	7.01e-05	0.000649	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	7.01e-05	0.000649	CcSEcCtD
Abacavir—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	6.99e-05	0.000647	CcSEcCtD
Abacavir—Arthralgia—Prednisone—systemic lupus erythematosus	6.99e-05	0.000647	CcSEcCtD
Abacavir—Myalgia—Prednisone—systemic lupus erythematosus	6.99e-05	0.000647	CcSEcCtD
Abacavir—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	6.98e-05	0.000646	CcSEcCtD
Abacavir—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	6.97e-05	0.000645	CcSEcCtD
Abacavir—Anxiety—Prednisone—systemic lupus erythematosus	6.96e-05	0.000644	CcSEcCtD
Abacavir—Alopecia—Methotrexate—systemic lupus erythematosus	6.96e-05	0.000644	CcSEcCtD
Abacavir—Insomnia—Dexamethasone—systemic lupus erythematosus	6.95e-05	0.000644	CcSEcCtD
Abacavir—Insomnia—Betamethasone—systemic lupus erythematosus	6.95e-05	0.000644	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	6.94e-05	0.000642	CcSEcCtD
Abacavir—Diarrhoea—Cyclosporine—systemic lupus erythematosus	6.93e-05	0.000641	CcSEcCtD
Abacavir—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	6.91e-05	0.00064	CcSEcCtD
Abacavir—Paraesthesia—Dexamethasone—systemic lupus erythematosus	6.9e-05	0.000639	CcSEcCtD
Abacavir—Paraesthesia—Betamethasone—systemic lupus erythematosus	6.9e-05	0.000639	CcSEcCtD
Abacavir—Discomfort—Prednisone—systemic lupus erythematosus	6.9e-05	0.000639	CcSEcCtD
Abacavir—Malnutrition—Methotrexate—systemic lupus erythematosus	6.86e-05	0.000635	CcSEcCtD
Abacavir—Hypersensitivity—Prednisolone—systemic lupus erythematosus	6.79e-05	0.000629	CcSEcCtD
Abacavir—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	6.76e-05	0.000626	CcSEcCtD
Abacavir—Urticaria—Triamcinolone—systemic lupus erythematosus	6.73e-05	0.000623	CcSEcCtD
Abacavir—Urticaria—Methylprednisolone—systemic lupus erythematosus	6.72e-05	0.000622	CcSEcCtD
Abacavir—Body temperature increased—Triamcinolone—systemic lupus erythematosus	6.7e-05	0.00062	CcSEcCtD
Abacavir—Dizziness—Cyclosporine—systemic lupus erythematosus	6.7e-05	0.00062	CcSEcCtD
Abacavir—Oedema—Prednisone—systemic lupus erythematosus	6.7e-05	0.00062	CcSEcCtD
Abacavir—Anaphylactic shock—Prednisone—systemic lupus erythematosus	6.7e-05	0.00062	CcSEcCtD
Abacavir—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	6.68e-05	0.000619	CcSEcCtD
Abacavir—Decreased appetite—Dexamethasone—systemic lupus erythematosus	6.68e-05	0.000619	CcSEcCtD
Abacavir—Decreased appetite—Betamethasone—systemic lupus erythematosus	6.68e-05	0.000619	CcSEcCtD
Abacavir—Infection—Prednisone—systemic lupus erythematosus	6.65e-05	0.000616	CcSEcCtD
Abacavir—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	6.64e-05	0.000615	CcSEcCtD
Abacavir—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	6.64e-05	0.000615	CcSEcCtD
Abacavir—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	6.63e-05	0.000614	CcSEcCtD
Abacavir—Fatigue—Dexamethasone—systemic lupus erythematosus	6.63e-05	0.000614	CcSEcCtD
Abacavir—Fatigue—Betamethasone—systemic lupus erythematosus	6.63e-05	0.000614	CcSEcCtD
Abacavir—Pain—Dexamethasone—systemic lupus erythematosus	6.58e-05	0.000609	CcSEcCtD
Abacavir—Pain—Betamethasone—systemic lupus erythematosus	6.58e-05	0.000609	CcSEcCtD
Abacavir—Nervous system disorder—Prednisone—systemic lupus erythematosus	6.57e-05	0.000608	CcSEcCtD
Abacavir—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	6.53e-05	0.000605	CcSEcCtD
Abacavir—Skin disorder—Prednisone—systemic lupus erythematosus	6.5e-05	0.000602	CcSEcCtD
Abacavir—Asthenia—Hydrocortisone—systemic lupus erythematosus	6.46e-05	0.000598	CcSEcCtD
Abacavir—Vomiting—Cyclosporine—systemic lupus erythematosus	6.44e-05	0.000596	CcSEcCtD
Abacavir—Rash—Cyclosporine—systemic lupus erythematosus	6.39e-05	0.000591	CcSEcCtD
Abacavir—Anorexia—Prednisone—systemic lupus erythematosus	6.38e-05	0.000591	CcSEcCtD
Abacavir—Dermatitis—Cyclosporine—systemic lupus erythematosus	6.38e-05	0.000591	CcSEcCtD
Abacavir—Pruritus—Hydrocortisone—systemic lupus erythematosus	6.37e-05	0.000589	CcSEcCtD
Abacavir—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	6.36e-05	0.000589	CcSEcCtD
Abacavir—Headache—Cyclosporine—systemic lupus erythematosus	6.34e-05	0.000587	CcSEcCtD
Abacavir—Anaemia—Methotrexate—systemic lupus erythematosus	6.34e-05	0.000587	CcSEcCtD
Abacavir—Feeling abnormal—Betamethasone—systemic lupus erythematosus	6.34e-05	0.000587	CcSEcCtD
Abacavir—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	6.34e-05	0.000587	CcSEcCtD
Abacavir—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	6.29e-05	0.000582	CcSEcCtD
Abacavir—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	6.29e-05	0.000582	CcSEcCtD
Abacavir—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	6.28e-05	0.000581	CcSEcCtD
Abacavir—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	6.24e-05	0.000578	CcSEcCtD
Abacavir—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	6.23e-05	0.000577	CcSEcCtD
Abacavir—Rash—Mycophenolate mofetil—systemic lupus erythematosus	6.23e-05	0.000577	CcSEcCtD
Abacavir—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	6.22e-05	0.000576	CcSEcCtD
Abacavir—Headache—Mycophenolate mofetil—systemic lupus erythematosus	6.19e-05	0.000573	CcSEcCtD
Abacavir—Malaise—Methotrexate—systemic lupus erythematosus	6.18e-05	0.000572	CcSEcCtD
Abacavir—Vertigo—Methotrexate—systemic lupus erythematosus	6.16e-05	0.00057	CcSEcCtD
Abacavir—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	6.16e-05	0.00057	CcSEcCtD
Abacavir—Leukopenia—Methotrexate—systemic lupus erythematosus	6.14e-05	0.000568	CcSEcCtD
Abacavir—Urticaria—Dexamethasone—systemic lupus erythematosus	6.11e-05	0.000565	CcSEcCtD
Abacavir—Urticaria—Betamethasone—systemic lupus erythematosus	6.11e-05	0.000565	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	6.1e-05	0.000565	CcSEcCtD
Abacavir—Dizziness—Prednisolone—systemic lupus erythematosus	6.09e-05	0.000564	CcSEcCtD
Abacavir—Asthenia—Triamcinolone—systemic lupus erythematosus	6.08e-05	0.000563	CcSEcCtD
Abacavir—Body temperature increased—Betamethasone—systemic lupus erythematosus	6.08e-05	0.000563	CcSEcCtD
Abacavir—Abdominal pain—Dexamethasone—systemic lupus erythematosus	6.08e-05	0.000563	CcSEcCtD
Abacavir—Abdominal pain—Betamethasone—systemic lupus erythematosus	6.08e-05	0.000563	CcSEcCtD
Abacavir—Body temperature increased—Dexamethasone—systemic lupus erythematosus	6.08e-05	0.000563	CcSEcCtD
Abacavir—Asthenia—Methylprednisolone—systemic lupus erythematosus	6.07e-05	0.000562	CcSEcCtD
Abacavir—Insomnia—Prednisone—systemic lupus erythematosus	6.06e-05	0.000561	CcSEcCtD
Abacavir—Nausea—Cyclosporine—systemic lupus erythematosus	6.02e-05	0.000557	CcSEcCtD
Abacavir—Paraesthesia—Prednisone—systemic lupus erythematosus	6.01e-05	0.000557	CcSEcCtD
Abacavir—Pruritus—Triamcinolone—systemic lupus erythematosus	6e-05	0.000555	CcSEcCtD
Abacavir—Cough—Methotrexate—systemic lupus erythematosus	5.98e-05	0.000554	CcSEcCtD
Abacavir—Pruritus—Methylprednisolone—systemic lupus erythematosus	5.98e-05	0.000554	CcSEcCtD
Abacavir—Dizziness—Hydrocortisone—systemic lupus erythematosus	5.95e-05	0.000551	CcSEcCtD
Abacavir—Convulsion—Methotrexate—systemic lupus erythematosus	5.94e-05	0.00055	CcSEcCtD
Abacavir—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	5.87e-05	0.000543	CcSEcCtD
Abacavir—Myalgia—Methotrexate—systemic lupus erythematosus	5.84e-05	0.00054	CcSEcCtD
Abacavir—Arthralgia—Methotrexate—systemic lupus erythematosus	5.84e-05	0.00054	CcSEcCtD
Abacavir—Decreased appetite—Prednisone—systemic lupus erythematosus	5.82e-05	0.000539	CcSEcCtD
Abacavir—Rash—Prednisolone—systemic lupus erythematosus	5.81e-05	0.000538	CcSEcCtD
Abacavir—Dermatitis—Prednisolone—systemic lupus erythematosus	5.81e-05	0.000537	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	5.8e-05	0.000537	CcSEcCtD
Abacavir—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	5.79e-05	0.000536	CcSEcCtD
Abacavir—Fatigue—Prednisone—systemic lupus erythematosus	5.77e-05	0.000534	CcSEcCtD
Abacavir—Headache—Prednisolone—systemic lupus erythematosus	5.77e-05	0.000534	CcSEcCtD
Abacavir—Discomfort—Methotrexate—systemic lupus erythematosus	5.77e-05	0.000534	CcSEcCtD
Abacavir—Vomiting—Hydrocortisone—systemic lupus erythematosus	5.72e-05	0.00053	CcSEcCtD
Abacavir—Rash—Hydrocortisone—systemic lupus erythematosus	5.67e-05	0.000525	CcSEcCtD
Abacavir—Dermatitis—Hydrocortisone—systemic lupus erythematosus	5.67e-05	0.000525	CcSEcCtD
Abacavir—Headache—Hydrocortisone—systemic lupus erythematosus	5.64e-05	0.000522	CcSEcCtD
Abacavir—Dizziness—Triamcinolone—systemic lupus erythematosus	5.6e-05	0.000519	CcSEcCtD
Abacavir—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	5.6e-05	0.000518	CcSEcCtD
Abacavir—Dizziness—Methylprednisolone—systemic lupus erythematosus	5.59e-05	0.000518	CcSEcCtD
Abacavir—Infection—Methotrexate—systemic lupus erythematosus	5.56e-05	0.000515	CcSEcCtD
Abacavir—Feeling abnormal—Prednisone—systemic lupus erythematosus	5.52e-05	0.000511	CcSEcCtD
Abacavir—Asthenia—Dexamethasone—systemic lupus erythematosus	5.52e-05	0.000511	CcSEcCtD
Abacavir—Asthenia—Betamethasone—systemic lupus erythematosus	5.52e-05	0.000511	CcSEcCtD
Abacavir—Nervous system disorder—Methotrexate—systemic lupus erythematosus	5.49e-05	0.000508	CcSEcCtD
Abacavir—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	5.48e-05	0.000507	CcSEcCtD
Abacavir—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	5.48e-05	0.000507	CcSEcCtD
Abacavir—Nausea—Prednisolone—systemic lupus erythematosus	5.47e-05	0.000507	CcSEcCtD
Abacavir—Pruritus—Betamethasone—systemic lupus erythematosus	5.44e-05	0.000504	CcSEcCtD
Abacavir—Pruritus—Dexamethasone—systemic lupus erythematosus	5.44e-05	0.000504	CcSEcCtD
Abacavir—Skin disorder—Methotrexate—systemic lupus erythematosus	5.44e-05	0.000503	CcSEcCtD
Abacavir—Vomiting—Triamcinolone—systemic lupus erythematosus	5.39e-05	0.000499	CcSEcCtD
Abacavir—Vomiting—Methylprednisolone—systemic lupus erythematosus	5.38e-05	0.000498	CcSEcCtD
Abacavir—Nausea—Hydrocortisone—systemic lupus erythematosus	5.35e-05	0.000495	CcSEcCtD
Abacavir—Rash—Triamcinolone—systemic lupus erythematosus	5.34e-05	0.000495	CcSEcCtD
Abacavir—Dermatitis—Triamcinolone—systemic lupus erythematosus	5.34e-05	0.000494	CcSEcCtD
Abacavir—Anorexia—Methotrexate—systemic lupus erythematosus	5.33e-05	0.000494	CcSEcCtD
Abacavir—Rash—Methylprednisolone—systemic lupus erythematosus	5.33e-05	0.000494	CcSEcCtD
Abacavir—Dermatitis—Methylprednisolone—systemic lupus erythematosus	5.33e-05	0.000493	CcSEcCtD
Abacavir—Urticaria—Prednisone—systemic lupus erythematosus	5.32e-05	0.000492	CcSEcCtD
Abacavir—Headache—Triamcinolone—systemic lupus erythematosus	5.31e-05	0.000491	CcSEcCtD
Abacavir—Headache—Methylprednisolone—systemic lupus erythematosus	5.3e-05	0.00049	CcSEcCtD
Abacavir—Body temperature increased—Prednisone—systemic lupus erythematosus	5.29e-05	0.00049	CcSEcCtD
Abacavir—Abdominal pain—Prednisone—systemic lupus erythematosus	5.29e-05	0.00049	CcSEcCtD
Abacavir—Diarrhoea—Betamethasone—systemic lupus erythematosus	5.26e-05	0.000487	CcSEcCtD
Abacavir—Diarrhoea—Dexamethasone—systemic lupus erythematosus	5.26e-05	0.000487	CcSEcCtD
Abacavir—Hypotension—Methotrexate—systemic lupus erythematosus	5.23e-05	0.000484	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	5.1e-05	0.000472	CcSEcCtD
Abacavir—Dizziness—Betamethasone—systemic lupus erythematosus	5.08e-05	0.000471	CcSEcCtD
Abacavir—Dizziness—Dexamethasone—systemic lupus erythematosus	5.08e-05	0.000471	CcSEcCtD
Abacavir—Insomnia—Methotrexate—systemic lupus erythematosus	5.06e-05	0.000469	CcSEcCtD
Abacavir—Nausea—Triamcinolone—systemic lupus erythematosus	5.03e-05	0.000466	CcSEcCtD
Abacavir—Paraesthesia—Methotrexate—systemic lupus erythematosus	5.03e-05	0.000465	CcSEcCtD
Abacavir—Nausea—Methylprednisolone—systemic lupus erythematosus	5.02e-05	0.000465	CcSEcCtD
Abacavir—Dyspnoea—Methotrexate—systemic lupus erythematosus	4.99e-05	0.000462	CcSEcCtD
Abacavir—Hypersensitivity—Prednisone—systemic lupus erythematosus	4.93e-05	0.000457	CcSEcCtD
Abacavir—Vomiting—Dexamethasone—systemic lupus erythematosus	4.89e-05	0.000453	CcSEcCtD
Abacavir—Vomiting—Betamethasone—systemic lupus erythematosus	4.89e-05	0.000453	CcSEcCtD
Abacavir—Decreased appetite—Methotrexate—systemic lupus erythematosus	4.87e-05	0.00045	CcSEcCtD
Abacavir—Rash—Dexamethasone—systemic lupus erythematosus	4.85e-05	0.000449	CcSEcCtD
Abacavir—Rash—Betamethasone—systemic lupus erythematosus	4.85e-05	0.000449	CcSEcCtD
Abacavir—Dermatitis—Dexamethasone—systemic lupus erythematosus	4.84e-05	0.000448	CcSEcCtD
Abacavir—Dermatitis—Betamethasone—systemic lupus erythematosus	4.84e-05	0.000448	CcSEcCtD
Abacavir—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	4.83e-05	0.000447	CcSEcCtD
Abacavir—Fatigue—Methotrexate—systemic lupus erythematosus	4.83e-05	0.000447	CcSEcCtD
Abacavir—Headache—Betamethasone—systemic lupus erythematosus	4.82e-05	0.000446	CcSEcCtD
Abacavir—Headache—Dexamethasone—systemic lupus erythematosus	4.82e-05	0.000446	CcSEcCtD
Abacavir—Asthenia—Prednisone—systemic lupus erythematosus	4.8e-05	0.000445	CcSEcCtD
Abacavir—Pain—Methotrexate—systemic lupus erythematosus	4.79e-05	0.000443	CcSEcCtD
Abacavir—Pruritus—Prednisone—systemic lupus erythematosus	4.74e-05	0.000439	CcSEcCtD
Abacavir—Feeling abnormal—Methotrexate—systemic lupus erythematosus	4.61e-05	0.000427	CcSEcCtD
Abacavir—Diarrhoea—Prednisone—systemic lupus erythematosus	4.58e-05	0.000424	CcSEcCtD
Abacavir—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	4.58e-05	0.000424	CcSEcCtD
Abacavir—Nausea—Dexamethasone—systemic lupus erythematosus	4.57e-05	0.000423	CcSEcCtD
Abacavir—Nausea—Betamethasone—systemic lupus erythematosus	4.57e-05	0.000423	CcSEcCtD
Abacavir—Urticaria—Methotrexate—systemic lupus erythematosus	4.45e-05	0.000412	CcSEcCtD
Abacavir—Dizziness—Prednisone—systemic lupus erythematosus	4.43e-05	0.00041	CcSEcCtD
Abacavir—Abdominal pain—Methotrexate—systemic lupus erythematosus	4.42e-05	0.00041	CcSEcCtD
Abacavir—Body temperature increased—Methotrexate—systemic lupus erythematosus	4.42e-05	0.00041	CcSEcCtD
Abacavir—Vomiting—Prednisone—systemic lupus erythematosus	4.26e-05	0.000394	CcSEcCtD
Abacavir—Rash—Prednisone—systemic lupus erythematosus	4.22e-05	0.000391	CcSEcCtD
Abacavir—Dermatitis—Prednisone—systemic lupus erythematosus	4.22e-05	0.000391	CcSEcCtD
Abacavir—Headache—Prednisone—systemic lupus erythematosus	4.2e-05	0.000388	CcSEcCtD
Abacavir—Hypersensitivity—Methotrexate—systemic lupus erythematosus	4.12e-05	0.000382	CcSEcCtD
Abacavir—Asthenia—Methotrexate—systemic lupus erythematosus	4.02e-05	0.000372	CcSEcCtD
Abacavir—Nausea—Prednisone—systemic lupus erythematosus	3.98e-05	0.000368	CcSEcCtD
Abacavir—Pruritus—Methotrexate—systemic lupus erythematosus	3.96e-05	0.000367	CcSEcCtD
Abacavir—Diarrhoea—Methotrexate—systemic lupus erythematosus	3.83e-05	0.000354	CcSEcCtD
Abacavir—Dizziness—Methotrexate—systemic lupus erythematosus	3.7e-05	0.000343	CcSEcCtD
Abacavir—Vomiting—Methotrexate—systemic lupus erythematosus	3.56e-05	0.000329	CcSEcCtD
Abacavir—Rash—Methotrexate—systemic lupus erythematosus	3.53e-05	0.000327	CcSEcCtD
Abacavir—Dermatitis—Methotrexate—systemic lupus erythematosus	3.53e-05	0.000326	CcSEcCtD
Abacavir—Headache—Methotrexate—systemic lupus erythematosus	3.51e-05	0.000325	CcSEcCtD
Abacavir—Nausea—Methotrexate—systemic lupus erythematosus	3.32e-05	0.000308	CcSEcCtD
